Target intelligence / Profile preview

Pseudomonas aeruginosa 30S ribosomal subunit (30S subunit)

Target
30S subunit
Molecular classification
Ribosomal subunit
01

Overview

The Pseudomonas aeruginosa 30S ribosomal subunit is the small subunit of the bacterial ribosome responsible for decoding mRNA during protein synthesis initiation. It forms the 30S initiation complex with initiation factors IF1, IF2, and IF3, where IF1 binds the A-site to block premature tRNA binding and prevent 50S subunit association until proper initiation. The subunit includes 16S rRNA and proteins like uS3 and uS13, which position mRNA and contact the 23S rRNA in the 70S ribosome. Structural features such as helix 44 (h44) serve as the primary binding site for aminoglycoside antibiotics, which induce miscoding by flipping out key nucleotides A1492/A1493. In pathogenic strains, mutations like those in uL6 alter intersubunit bridges (e.g., H69 bending), conferring aminoglycoside resistance by destabilizing ribosome assembly and reducing drug binding efficacy. This makes the 30S subunit a validated antibacterial target, though resistance via conformational changes poses therapeutic challenges. Cryo-EM studies reveal unique P. aeruginosa features, such as shorter H45/H16 helices, highlighting species-specific vulnerabilities exploitable for novel inhibitors.

Other names
small ribosomal subunit30S initiation complex
02

Mechanism of action

Binding to helix 44 (h44) of 16S rRNA, displacing nucleotides A1492/A1493, causing miscoding, blocking intersubunit rotation, inhibiting translocation; secondary binding to helix 69 (H69) of 23S rRNA

03

Biological functions

Protein synthesis initiationTranslationmRNA positioningtRNA binding prevention at A-site
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Ribosomal mutations (e.g., uL6) cause conformational changes leading to antibiotic resistance, reduced 70S stability, slower bacterial growth
06

Interacting drugs

Aminoglycosides

Beyond the preview

Go deeper on Pseudomonas aeruginosa 30S ribosomal subunit (30S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudomonas aeruginosa 30S ribosomal subunit (30S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call